About Boji Medical Technology Company

The company was founded in 2002 and listed on the Shenzhen ChiNext Board in 2015. It is China's leading full-service CRO and the first publicly listed CRO whose core business is clinical trials. As a professional CRO service provider, the company offers end-to-end, one-stop CRO solutions for the research, development, and manufacturing of new drugs and medical devices to pharmaceutical companies and other research institutions both domestically and internationally. Its main offerings include preclinical research services, clinical research services, other consulting services, and CDMO services. The company has received numerous accolades, including being named among the Top 20 Chinese Pharmaceutical Outsourcing Companies, a "Little Giant" of Science and Technology, a Well-Known Trademark of Guangzhou, a Brand Service Provider in China's Pharmaceutical Industry, a "Little Giant" of Science and Technology, one of the "Top 10 Most Competitive Pharmaceutical Services Enterprises in China 2023," one of the "Top 20 Chinese Pharmaceutical CROs in 2022," one of the "Top 50 Chinese Pharmaceutical R&D Companies in 2022," one of the "Top 20 Chinese Pharmaceutical CROs in 2024 (ranked 8th)," one of the "Top 50 Chinese Pharmaceutical R&D Companies in 2024," the Excellence Award in the "Top 100 Chinese Life Sciences Service Enterprises," one of the "Top 20 Chinese Pharmaceutical CROs in 2025 (ranked 6th)," the "Qimingxing Award for Best CRO Partner in the CGT Field (ranked 1st)," inclusion in KPMG's inaugural "Top 50 Health Tech Companies," one of the "Top 20 Chinese Clinical CROs in 2025," and election as a member of the China Anesthesia and Analgesia GCP Research Alliance, among others.